Insider Brief
- The House Committee on Science, Space, and Technology advanced the National Quantum Initiative Reauthorization Act, moving legislation to update U.S. quantum policy closer to a full House vote.
- The bill seeks to shift federal focus toward commercialization, workforce development, supply chain resilience, and coordination with allied nations.
- Lawmakers highlighted uncertainty around fiscal 2026 funding levels as a challenge to determining appropriate resource allocation under the legislation.
- Image: Photo by Ben Mater on Unsplash
The U.S. House Committee on Science, Space, and Technology has advanced legislation that would extend and update the federal government’s quantum technology strategy, moving the effort one step closer to a full House vote, according to a press release.
Lawmakers approved the National Quantum Initiative Reauthorization Act (H.R. 8462) during an April 29 markup session, a procedural stage where members debate, amend, and ultimately decide whether to send a bill forward. The committee’s approval signals bipartisan support for revisiting the U.S. approach to quantum research and commercialization at a time of intensifying global competition.
In the release, the committee writes the act:
- Modernizes and reauthorizes federal quantum research programs
- Strengthens coordination across key federal agencies, including the addition of NASA as a formal quantum research partner
- Supports workforce development to meet growing quantum industry demands
- Expands collaboration with allies to maintain U.S. competitiveness
The bill would renew and expand the framework first established under the act, which created a coordinated federal program spanning agencies such as the Department of Energy, National Science Foundation, and National Institute of Standards and Technology. That 2018 law focused heavily on building foundational research capacity and aligning federal investments across quantum computing, sensing and communications.
The updated legislation shifts emphasis toward deployment. According to a summary of the bill, H.R. 8462 calls for stronger efforts to transition quantum technologies out of the lab and into commercial and operational environments. It also includes provisions aimed at expanding workforce development programs, strengthening domestic supply chains, and increasing collaboration with allied nations..
Quantum’s Next Phase
By advancing the bill, the committee has clarified congressional priorities for the next phase of quantum policy — placing greater weight on commercialization, coordination, and workforce readiness alongside continued research funding.
“Quantum technology is not a distant concept—it is a foundational capability that will shape the future of computing, communications, and national security,” said Chairman Brian Babin. “I’m proud to see this forward-looking legislation pass out of Committee. It takes an important step toward strengthening American leadership, advancing real-world quantum capabilities, and helping secure our nation’s long-term economic strength and strategic advantage.”
“This is a big win for America and a sign we are firing on all cylinders,” said Energy Subcommittee Chairman Randy Weber. “I was proud to lead this bill, and the bipartisan momentum behind it shows real resolve to keep America leading in the technologies that will shape the future as we push this legislation closer to the finish line. This bill helps ensure the next breakthroughs in quantum science are written by the United States of America, not our foreign adversaries. As we write another proud chapter in our Nation’s storybook, we remind the world America’s greatest chapters are still ahead.”
The act also includes U.S. Representative Emilia Sykes (OH-13) bills that are focused on advancing healthcare innovation and strengthening the quantum workforce, including Quantum for Health Act, which would expand the use of quantum technology in biomedical research and find new treatments, and the Support for Quantum Supply Chains Act, which would support the next generation of quantum workers.
“These bipartisan efforts are about making sure cutting-edge technology translates into real-world benefits for patients and families,” said Rep. Sykes, in a statement. “Ohio is leading the way on quantum innovation, and I’m proud to see these bills move forward as part of this package. I will keep working to ensure we build on that leadership and deliver results for our communities.”
The representative said that in 2023, the Cleveland Clinic, in partnership with IBM, unveiled the first quantum computer in the world dedicated to healthcare research, now being used to accelerate drug discovery, improve disease prediction models and analyze complex biomedical data.
“Quantum computing is rapidly becoming an important new tool in biomedical research, helping scientists move faster to discover new medicines, improve treatments, and address some of our most pressing health challenges. Cleveland Clinic has been at the forefront of this work. As the first healthcare system to invest in quantum and install a quantum computer within a research facility, we made an early commitment to exploring how quantum applications can advance healthcare and life sciences. As healthcare organizations and researchers continue to rely on these emerging tools, it is important that Congress supports innovation that can strengthen patient care, advance medical discovery, and reinforce our nation’s leadership in science and technology. Congresswoman Sykes’s introduction of the Quantum for Health Act is a meaningful step toward ensuring healthcare is part of that future,” said Cleveland Clinic Chief Research Information Officer Dr. Lara Jehi, in the statement.
Uncertainties
The timing of the act reflects broader concern in Washington that U.S. leadership in quantum research has not yet translated into comparable gains in manufacturing, standards-setting, or large-scale industry adoption. Policymakers have pointed to growing investments from China and the European Union as evidence that competition is accelerating across multiple fronts
Lofgren said she is concerned that as the Chinese government is adding more funds for science and research, the Trump administration is cutting efforts that could boost quantum technologies.
Lofgren said: “The Chinese Communist Party is in position to outspend our efforts again this year and for the next five, while the U.S. administration is taking a sledgehammer to U.S. science agencies, including the leading agencies for quantum information science.”
Rep. Zoe Lofgren (D-Calif.), ranking committee member, also cautioned that funding uncertainties remain.
In an official prepared statement, Lofgrensaid “Unfortunately, we do not yet have fiscal year 2026 spending plans for the agencies, which makes it difficult for us to adequately project appropriate spending levels in this bill. Chairman Babin has assured me he will work with me to address this challenge so we can be assured all of our relevant agencies have the resources to carry out the activities authorized under this bill before this bill moves to the floor.”
The legislation now heads to the U.S. House of Representatives for consideration. If passed, it would require Senate approval before being sent to the president for signature.
